Medicinal Alchemy, circa 1512

By Cristina Luiggi Medicinal Alchemy, circa 1512 Related Articles The art of alchemy Stem cell alchemy The discovery of DNA, circa 1869 During the Middle Ages, alchemists developed sophisticated ways to tap the medicinal powers of the Earth’s bounty. Depending on the ailment being treated, flowers, herbs, spices, minerals, and animal flesh all potentially held cures, which could be extracted employing methods not unlike those used by modern organ

Written byCristina Luiggi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The art of alchemy

Stem cell alchemy

The discovery of DNA, circa 1869

During the Middle Ages, alchemists developed sophisticated ways to tap the medicinal powers of the Earth’s bounty. Depending on the ailment being treated, flowers, herbs, spices, minerals, and animal flesh all potentially held cures, which could be extracted employing methods not unlike those used by modern organic chemists and pharmacologists. Liber de Arte Distillandi, published in present day Strasbourg, France, in 1512, is a compilation of centuries of knowledge intended by its author, German surgeon Hieronymus Brunschwig, to serve as a layman’s guide to the preparation of these natural medicines.

With detailed instructions, ranging from the right times to collect herbs to the exact specifications for constructing distillation equipment, Brunschwig hoped to make medicinal alchemy accessible to “the common people that dwell far from medicines and physicians and for them that not be able to pay for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies